Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Stewart AK, Bergsagel PL, Greipp PR, Dispenzieri A, Gertz MA, Hayman SR, Kumar S, Lacy MQ, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Reeder CB, Roy V, Kyle RA, Rajkumar SV, Fonseca R. Stewart AK, et al. Among authors: zeldenrust sr. Leukemia. 2007 Mar;21(3):529-34. doi: 10.1038/sj.leu.2404516. Epub 2007 Jan 18. Leukemia. 2007. PMID: 17230230
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis.
Hwa YL, Gertz MA, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Kapoor P, Zeldenrust SR, Leung N, Hayman SR, Gonsalves WI, Kourelis TV, Warsame R, Go RS, Muchtar E, Hobbs MA, Fonder AL, Russell S, Kyle RA, Rajkumar SV, Dispenzieri A. Hwa YL, et al. Among authors: zeldenrust sr. Leukemia. 2019 May;33(5):1268-1272. doi: 10.1038/s41375-019-0400-5. Epub 2019 Feb 8. Leukemia. 2019. PMID: 30737485
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
Nandakumar B, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Siddiqui M, Zeldenrust S, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Nandakumar B, et al. Among authors: zeldenrust s. Clin Lymphoma Myeloma Leuk. 2020 Jan;20(1):53-56. doi: 10.1016/j.clml.2019.09.624. Epub 2019 Oct 9. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31685378 Free PMC article.
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis.
Muchtar E, Gertz MA, Kourelis TV, Sidana S, Go RS, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Lisa Hwa Y, Gonsalves W, Warsame R, Russell S, Lust JA, Lin Y, Zeldenrust S, Rajkumar SV, Kyle RA, Kumar SK, Dispenzieri A. Muchtar E, et al. Among authors: zeldenrust s. Leukemia. 2020 Apr;34(4):1135-1143. doi: 10.1038/s41375-019-0655-x. Epub 2019 Nov 22. Leukemia. 2020. PMID: 31758090
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV. Kumar SK, et al. Among authors: zeldenrust sr. Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25. Leukemia. 2014. PMID: 24157580 Free PMC article.
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Hwa YL, Gonsalves W, Kyle RA, Dispenzieri A. Kourelis TV, et al. Among authors: zeldenrust sr. Leukemia. 2016 May;30(5):1079-85. doi: 10.1038/leu.2015.344. Epub 2015 Dec 16. Leukemia. 2016. PMID: 26669974
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI, Rajkumar SV, Dispenzieri A, Dingli D, Timm MM, Morice WG, Lacy MQ, Buadi FK, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa L, Kourelis TV, Kyle RA, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: zeldenrust sr. Leukemia. 2017 Jan;31(1):130-135. doi: 10.1038/leu.2016.205. Epub 2016 Jul 26. Leukemia. 2017. PMID: 27457702 Free PMC article.
Natural history of t(11;14) multiple myeloma.
Lakshman A, Alhaj Moustafa M, Rajkumar SV, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Lakshman A, et al. Among authors: zeldenrust sr. Leukemia. 2018 Jan;32(1):131-138. doi: 10.1038/leu.2017.204. Epub 2017 Jun 27. Leukemia. 2018. PMID: 28655925
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma.
Binder M, Rajkumar SV, Ketterling RP, Greipp PT, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kyle RA, Kumar SK. Binder M, et al. Among authors: zeldenrust sr. Blood Cancer J. 2017 Sep 1;7(9):e600. doi: 10.1038/bcj.2017.83. Blood Cancer J. 2017. PMID: 28862698 Free PMC article.
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.
Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, Go RS, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Kumar SK. Sidana S, et al. Among authors: zeldenrust sr. Leukemia. 2018 Mar;32(3):729-735. doi: 10.1038/leu.2017.286. Epub 2017 Sep 18. Leukemia. 2018. PMID: 28919633
183 results